Centro de Investigación Médica Aplicada-ko ikertzaileekin lankidetzan egindako argitalpenak (50)

2017

  1. Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

    Scientific Reports, Vol. 7

2014

  1. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool

    Neuro-Oncology, Vol. 16, Núm. 4, pp. 520-527

2013

  1. MicroRNAs in colorectal cancer

    MicroRNAs in Cancer (CRC Press), pp. 177-219

  2. Pint lincrna connects the p53 pathway with epigenetic silencing by the polycomb repressive complex 2

    Genome Biology, Vol. 14, Núm. 9

2012

  1. Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer

    European Journal of Cancer, Vol. 48, Núm. 12, pp. 1774-1780

  2. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array

    World Journal of Gastroenterology, Vol. 18, Núm. 7, pp. 637-645

  3. MiRNAs and lincRNAs: Could they be considered as biomarkers in colorectal cancer?

    International Journal of Molecular Sciences, Vol. 13, Núm. 1, pp. 840-865

  4. RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC

    Lung Cancer, Vol. 75, Núm. 3, pp. 306-312

2011

  1. Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy

    European Journal of Cancer, Vol. 47, Núm. 6, pp. 839-847

  2. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma

    BJU International, Vol. 107, Núm. 11, pp. 1833-1838

  3. DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer

    Oncogene, Vol. 30, Núm. 6, pp. 668-678

  4. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas

    PLoS ONE, Vol. 6, Núm. 10

  5. Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

    Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4155-4166

  6. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells

    Stem Cells, Vol. 29, Núm. 11, pp. 1661-1671

  7. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer

    Journal of Surgical Oncology, Vol. 103, Núm. 5, pp. 411-415

  8. Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan

    Pharmacogenomics Journal, Vol. 11, Núm. 6, pp. 429-436

2010

  1. A semi-physiological-based pharmacokinetic/pharmacodynamic model to describe the effects of topotecan on B-lymphocyte lineage cells

    Pharmaceutical Research, Vol. 27, Núm. 3, pp. 431-441

  2. Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2

    Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 291-293

  3. Development of a DNA microelectrochemical biosensor for CEACAM5 detection

    IEEE Sensors Journal, Vol. 10, Núm. 8, pp. 1368-1374

  4. MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer

    Oncology, Vol. 77, Núm. SUPPL. 1, pp. 75-89